Abstract
Exposure of primary rat glial cells, mostly astrocytes, to heat-inactivated Mycoplasma fermentans triggers the production of tumor necrosis factor α (TNFα) nitric oxide (NO) and prostaglandin E2 (PGE2). To attenuate the production of these proinflammatory mediators, four agents: aminoguanidine, pentoxifylline, thalidomide and IL-10 were added to astrocyte cultures. Aminoguanidine (1 and 3 mM), an inhibitor of inducible nitric oxide synthase (iNOS), suppressed the production of the three mediators. TNFα was the most sensitive to thalidomide, showing dose-response inhibition at concentrations of 20 μg/ml, 50 μg/ml and 250 μg/ml. PGE2 was affected only by concentrations of 50 μg/ml and 250 μg/ml, whereas NO responded solely to the highest amount of this inhibitor. The cytokine IL-10, at 10 U and 50 U, inhibited only TNFα production. Our results imply that selective suppression of proinflammatory mediators by various agents may prove feasible for amelioration of central nervous system inflammatory diseases.
Similar content being viewed by others
REFERENCES
Razin, S. and J. G. Tully. 1995. In: Molecular and Diagnostic Procedures in Mycoplasmology. Vol. 1 Molecular characterization. pp 1-25, Academic Press. San Diego, New York, Boston, London, Sydney, Tokyo, Toronto.
Gabridge, M. G., K. F. Candler, and M. Daniels. 1985. In: The Mycoplasmas. Vol. 4. Academic Press, New York, pp 312-352.
Casswell, G. H. and B. C. Cole. 1981, Mycoplasmas as agents of human disease. N. Engl. J. Med. 304, 80-89.
Gallily, R., T. Sher, P. Ben-Av, and J. Loewenstein. 1989, Tumor necrosis factor as a mediator of Mycoplasma orale-induced tumor cell lysis by macrophages. Cellular Immunology, 121, 146-153.
Gallily, R., M. Salman, M. Tarshis, and S. Rottem. 1992, Mycoplasma fermentans (incognitus strain) induces TNFα and IL-1 production by human monocytes and murine macrophages. Immunology Letters, 34, 27-30.
Rosendal, S., S. Levisohn, and R. Gallily. 1995, Cytokines induced in vitro by Mycoplasma mycoides ssp. Mycoides, large colony type. Veterinary Immunol. and Immunopathology, 44, 269-278.
Avron, A. and R. Gallily. 1995. Mycoplasma stimulates the production of oxidative radicals by murine peritoneal macrophages. J. Leuk. Biol. 57, 264-268.
Brenner, T., A. Yamin, O. Abramsky, and R. Gallily. 1993. Stimulation of tumor necrosis factor-α production by mycoplasms. Brain Research 608, 273-279.
Brenner, T., A. Yamin, and R. Gallily, 1994. Mycoplasma triggering of nitric oxide production by central nervous system glial cells and its inhibition by glucocorticoids. Brain Research, 641, 51-56.
Lo, S. C., M. S. Dawson, D. M. Wong, P. B. Newton, M. A. Somda, W. F. Engler, R. Y. H. Wand, J. W. K. Shin, H. J. Alter, and D. J. Wear. 1989. Identification of Mycoplasma incognitus infection in a patient with AIDS, an immunohistochemical, in situ hybridization and ultrastructural study. Am. J. Top. Med. Hyg. 41, 601-616.
Maimone, D., S. Gregory, B. G. W. Arnason, and A. T. Regar, 1991. Cytokine levels in cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmunol, 32, 601-616.
Price, R. W., B. Brew, J. Siditis, M. Rosenblum, A. C. Scheck, and P. Cleary, 1988. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science, 239, 586-592.
Brenner, T., S. Brocke, F. Szater, R. A. Sober, J. F. Parkinson, D. H. Perez, and L. Steinman, 1997, Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158, 2940-2941.
Sampaio, E. P., E. N. Sarno, R. Gallily, Z. A. Cohn, and G. Kaplan. 1991, Thalidomide selectively inhibits tumor necrosis factor α production by stimulated human monocytes. J. Exp. Med., 173, 699-703.
Tilg, H., B. Eibl, M. Pihl, A. GÄchter, M. Herold, J. Brankova, C. Huber, and D. Niederwieser. 1993, Immune response modulation by pentoxifylline in vitro. Transplantation, 56, 196-201.
Moore, K. W., A. O'Garra, Pene de Waal Malefy, P. Vieira, and T. R. Mosmann. 1993. Interleukin 10, Annu. Rev. Immunol. 11, 165-190.
Brenner, T., R. P. Lisak, A. Rostami, D. E. Pleasure, and D. H. Silberberg. 1986, Astrocytes, oligodendrocytes and Schwann cells share a common antigenic determinant that cross-reacts with myelin basic protein: identification with monoclonal antibody. J. Neurosci. 6, 1925-1933.
Amit, Y. and T. Brenner. 1993. Age-dependent sensitivity of cultured rat glial cells to bilirubin toxicity. Exp. Neurol. 121, 248-255.
Sher, T., S. Rottem, and R Gallily. 1990. Mycoplasma capricolum membranes induce tumor necrosis factor by a mechanism different from that of lipopolysaccharide. Cancer Immunol. Immunother., 31, 86-92.
Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage de-activation by interleukin-10. J. Exp. Med., 174, 1549-1555.
Lalani, I., K. Bhol, and A. R. Ahmed. 1997, Interleukin-10, biology, role in inflammation and autoimmunity. Ann. Allergy-Asthma-Immunol., 79, 469-483.
Bo, L., T. M. Dawson, S. Wesselingh, S. Mork, S. Choi, P. A. Kong, D. Hanley, and B. D. Trapp. 1994, Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778-786.
Oliver, S. J., T. P. Cheng, M. L. Banquerigo, and E. Brahn. 1988. The effect of thalidomide and 2 analogs on collagen-induced arthritis. J. Rheumatol. 25, 964-967.
Klausner, J. F., V. H. Freedman, and G. Kaplan. 1996. Thalidomide as an anti-TNF alpha inhibitor: Implication for clinical use. Clin. Immunol. Immunopathol., 8, 219-223.
Moeira, A. L., E. P. Sampaio, A. Zmuidzinas, P. Frindt, K. A., Smith, and G. Kaplan. 1993. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med., 177, 1675-1680.
Han, J., P. Thompson, and B. Beutler. 1990. Dexamethasone and pentoxifylline inhibit endotoxin induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med., 172, 391-394.
Schmidt-Cloudhury, A., G. T. Furuta, J. A. Lavigne, S. J. Galli, and B. K. Wershil, 1996. The regulation of tumor necrosis factor production in murine mast cells: pentoxifylline or dexamathasone inhibits IgE-dependent production of the TNF-alpha by distinct mechanisms. Cell. Immunol., 171, 140-146.
Bogdan, C., Y. Vodovotz and C. Nathan, 1991. Macrophage deactivation by interleukin 10. J. Exp. Med., 174, 1549-1555.
Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah, 1995. Interleukin (IL) 10 inhibits nuclear factor β (NF Kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem., 270, 9558-9582.
Shri Kant, P., and E. N. Benveniste, 1996. The central nervous system as an immunocompetent organ. J. Immunol. 157, 1819-1822.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gallily, R., Kipper-Galperin, M. & Brenner, T. Mycoplasma fermentans—Induced Inflammatory Response of Astrocytes: Selective Modulation by Aminoguanidine, Thalidomide, Pentoxifylline and IL-10. Inflammation 23, 495–505 (1999). https://doi.org/10.1023/A:1020234321879
Issue Date:
DOI: https://doi.org/10.1023/A:1020234321879